AstraZeneca - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : AstraZeneca

Top of Directory » All Categories » by Company » AstraZeneca



  • A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects

    Condition:   Healthy
    Interventions:   Drug: AZD9164 Turbuhaler®;   Drug: Placebo Turbuhaler®
    Sponsor:   AstraZeneca
    Not yet recruiting - verified November 2009
  • Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

    Condition:   Peptic Ulcer Disease
    Interventions:   Drug: Esomeprazole/ASA Fixed Combination;   Drug: Esomeprazole;   Drug: ASA
    Sponsor:   AstraZeneca
    Not yet recruiting - verified November 2009
  • A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

    Condition:   Chronic Obstructive Pulmonary Disease
    Intervention:  
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009
  • Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

    Condition:   Adult ADHD
    Interventions:   Drug: AZD1446;   Drug: AZD1446;   Drug: AZD1446;   Drug: Placebo
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009
  • Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients

    Condition:   Chronic Obstructive Pulmonary Disease
    Intervention:  
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009
  • Gefitinib 500mg Versus 250mg in Patients With Non-Small Cell Lung Cancer (NSCLC) With Stable Disease After a Month Treatment of Gefitinib 250mg

    Condition:   Non-small Cell Lung Cancer
    Intervention:   Drug: Gefitinib 500mg/Gefitinib 250mg
    Sponsors:   Sun Yat-sen University;   AstraZeneca
    Recruiting - verified November 2009
  • Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin

    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: Saxagliptin;   Drug: Glimepiride
    Sponsors:   AstraZeneca;   Bristol-Myers Squibb
    Recruiting - verified November 2009
  • Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes

    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: Saxagliptin;   Drug: Metformin
    Sponsors:   AstraZeneca;   Bristol-Myers Squibb
    Recruiting - verified November 2009
  • Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects

    Condition:   Healthy
    Intervention:   Drug: 14C-AZD1236
    Sponsor:   AstraZeneca
    Terminated - verified November 2009
  • Investigate the Effect of Different Doses of AZD3355 as add-on to Proton Pump Inhibitor (PPI) in Gastroesophageal Reflux Disease (GERD) Patients With Partial Response to PPI

    Conditions:   Gastroesophageal Reflux Disease;   Acid Reflux;   Heartburn;   Regurgitation
    Interventions:   Drug: AZD3355;   Drug: AZD3355;   Drug: AZD3355;   Drug: AZD3355;   Drug: Placebo
    Sponsor:   AstraZeneca
    Recruiting - verified October 2009
  • Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer

    Condition:   Carcinoma, Non Small Cell Lung
    Interventions:   Drug: ZD6474 (vandetanib);   Drug: Faslodex (Fulvestrant)
    Sponsors:   University of Wisconsin, Madison;   AstraZeneca;   University of Pittsburgh
    Not yet recruiting - verified October 2009
  • Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

    Condition:   Type 2 Diabetes Mellitus (T2DM)
    Interventions:   Drug: Dapagliflozin;   Drug: Metformin XR;   Drug: Glucophage
    Sponsors:   Bristol-Myers Squibb;   AstraZeneca
    Not yet recruiting - verified October 2009
    • Menu
    Find Paid Clinical Trials